We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidance on Developing Drugs to Treat Epidermolysis Bullosa
FDA Issues Guidance on Developing Drugs to Treat Epidermolysis Bullosa
The FDA released final guidance for sponsors of drugs to treat or prevent serious flare-ups of skin disorders known collectively as epidermolysis bullosa (EB).